Gene therapy’s first out-and-out cure has finally gotten a customer.
Last year, GlaxoSmithKline unveiled a commercial gene therapy called Strimvelis. It's a treatment that uses a virus to add a missing gene to the bone marrow of children who suffer from a severe immune deficiency disease, which leaves them with almost no defense against viruses, bacteria, or fungi. With a dizzying $665,000 price tag, the treatment seems so effective it even has a money-back guarantee in case it doesn’t work. Our own Emily Mullin describes how it’s now being put to use.
Get The Download! Sign up here to have it delivered free to your inbox.
The White House may be leaning towards a Paris climate pact withdrawl.
President Trump rushed to dismantle climate policies enacted by Obama, but has been slower to decide whether the U.S. should exit the Paris climate deal. Now, the Washington Post reports that his aides may be increasingly inclined towards quitting–a shift from previous thinking. The New York Times says a decision could rest on a single phrase in the agreement: whether a country’s ability to “adjust” emissions targets can allow for weakening, as well as strengthening, commitments.
A Chinese quantum chip has a 1940s computer beat.
Researchers from eastern China have announced that their quantum device, which uses trapped photons as its qubits, is being used to perform real calculations. But don't get too excited: in experiments described in Nature Photonics, their chip was put to work on specific tasks that it crunched through 10 times faster than the world's first electronic computer from the 1940s, ENIAC, would. Clearly not quantum supremacy, but Google promises to crack that nut before 2017 is out.
"The equivalent of a fender-bender in the air is likely death."
— Sebastian Thrun, computer scientist, entrepreneur, and CEO of flying car firm Kitty Hawk, discusses the safety of airborne automobiles.